Karachi: The KSE-100 Index experienced a significant drop, shedding 1,963 points to close at 164,590, as over 1,503 million shares exchanged hands. The stock market witnessed notable price changes, with MUREB, ILP, and AGP leading the gains, while BAHL, HMB, and PTC topped the decliners' list. Trading activity was predominantly centered around sectors such as Technology, Investment Companies, and Banks.
In other developments, Pakistan's power tariff has been set at Rs22.98 per kWh under a new package introduced by the Prime Minister. Meanwhile, rice exports to China have surged by 63% in the third quarter, signaling a strong agricultural trade relationship between the two nations.
The government has announced a series of tax fraud arrests, as it continues to tackle issues of financial misconduct. Public debt levels have once again exceeded the prescribed limits, raising concerns about fiscal management. Foreign aid in the form of loans, grants, and NPC has amounted to USD 1.82 billion in the first quarter.
Diplomatic efforts are underway as Islamabad seeks Poland's support for the GSP+ status, while Qatar has expressed interest in investing in Reko Diq and Pakistan's airports. The Pak-Afghan border stations have seen partial restoration of Afghan transit trade, although closures have resulted in increased prices of essential goods.
Pakistan is also seeking Dutch investment for key sectors, as housing loans introduce a mix of optimism and skepticism among stakeholders. The State Bank of Pakistan's reserves have seen a slight increase of $14 million.
In terms of international cooperation, both Pakistan and China are making strides in green initiatives. However, Punjab is facing criticism for its handling of wheat distribution to two other provinces.
The automotive sector is seeing a shift, with used cars being targeted at expatriates, while IT firms are increasingly focusing on the Middle East and Europe. Additionally, the local production of advanced drugs for diabetes and obesity has commenced, and the nation aims to achieve $30 billion in medical exports.
Lastly, KE has reviewed tariff cuts by Nepra, cautioning that these could impact operational functions.